Antiemetic Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063796
  • May 2021
  • Pharmaceuticals
  • 141 Pages
The global Antiemetic Drugs market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Antiemetic Drugs market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Antiemetic Drugs market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Antiemetic Drugs market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, JOHNSON AND JOHNSON, SANOFI, MERCK AND CO., NOVARTIS AG, BRISTOL-MYERS SQUIBB, ASTELLAS PHARMA, INC., ELI LILLY AND COMPANY, ABBOTT, DR. REDDY\'S LABORATORIES LTD, Pfizer, Baxter International, Cipla Ltd., LGM Pharma, ZETA PHARMA
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Antiemetic Drugs market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Antiemetic Drugs market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Antiemetic Drugs market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Antiemetic Drugs market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Antiemetic Drugs Market:
The Antiemetic Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, JOHNSON AND JOHNSON, SANOFI, MERCK AND CO., NOVARTIS AG, BRISTOL-MYERS SQUIBB, ASTELLAS PHARMA, INC., ELI LILLY AND COMPANY, ABBOTT, DR. REDDY\'S LABORATORIES LTD, Pfizer, Baxter International, Cipla Ltd., LGM Pharma, ZETA PHARMA

Antiemetic Drugs Market Segment Analysis:
By Drug Type
5-HT3 Receptor Antagonists
Dopamine Antagonists
NK1 Receptor Antagonist
Antihistamines
Cannabinoids
Benzodiazepines
Anticholinergics
Others
Application
Chemotherapy
Motion Sickness
Gastroenteritis
Opioid Analgesics
Dizziness
Others

Geographic Coverage for Antiemetic Drugs Market:
The market research report on global Antiemetic Drugs market offers complete analysis across various regions across the world. The Antiemetic Drugs market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Antiemetic Drugs market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Antiemetic Drugs Market Value and Forecast
  • US
  • Canada
Europe Antiemetic Drugs Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Antiemetic Drugs Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Antiemetic Drugs Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Antiemetic Drugs Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Antiemetic Drugs market report:
  • The report provides key trends of the global Antiemetic Drugs market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Antiemetic Drugs industry
  • The report covers all the recent developments of the Antiemetic Drugs market and helps to provide current industry updates
  • The report covers a detailed look over the global Antiemetic Drugs Industry and provides with significant actionable insights
  • The Antiemetic Drugs market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Antiemetic Drugs market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Antiemetic Drugs market
  • Comprehensive analysis of the Antiemetic Drugs market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Antiemetic Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Antiemetic Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Antiemetic Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Antiemetic Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Antiemetic Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
  • JOHNSON AND JOHNSON
  • SANOFI
  • MERCK AND CO.
  • NOVARTIS AG
  • BRISTOL-MYERS SQUIBB
  • ASTELLAS PHARMA, INC.
  • ELI LILLY AND COMPANY
  • ABBOTT
  • DR. REDDY'S LABORATORIES LTD
  • Pfizer
  • Baxter International
  • Cipla Ltd.
  • LGM Pharma
  • ZETA PHARMA
  • 5-HT3 Receptor Antagonists
  • Dopamine Antagonists
  • NK1 Receptor Antagonist
  • Antihistamines
  • Cannabinoids
  • Benzodiazepines
  • Anticholinergics
  • Others
  • Chemotherapy
  • Motion Sickness
  • Gastroenteritis
  • Opioid Analgesics
  • Dizziness
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Antiemetic Drugs Market Snapshot
          2.1.1. Global Antiemetic Drugs Market By Drug Type,2019
               2.1.1.1.5-HT3 Receptor Antagonists
               2.1.1.2.Dopamine Antagonists
               2.1.1.3.NK1 Receptor Antagonist
               2.1.1.4.Antihistamines
               2.1.1.5.Cannabinoids
               2.1.1.6.Benzodiazepines
               2.1.1.7.Anticholinergics
               2.1.1.8.Others
          2.1.2. Global Antiemetic Drugs Market By Application,2019
               2.1.2.1.Chemotherapy
               2.1.2.2.Motion Sickness
               2.1.2.3.Gastroenteritis
               2.1.2.4.Opioid Analgesics
               2.1.2.5.Dizziness
               2.1.2.6.Others
          2.1.3. Global Antiemetic Drugs Market By End-use,2019
          2.1.4. Global Antiemetic Drugs Market By Geography,2019

3. Global Antiemetic Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Antiemetic Drugs Market Size (US$), By Drug Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Type, 2020
     4.2. Global Antiemetic Drugs Market Size (US$), By Drug Type, 2018 – 2028

5. Global Antiemetic Drugs Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Antiemetic Drugs Market Size (US$), By Application, 2018 – 2028

6. Global Antiemetic Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Antiemetic Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Antiemetic Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Antiemetic Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Antiemetic Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Antiemetic Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.2.3. North America Antiemetic Drugs Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Antiemetic Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Antiemetic Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Antiemetic Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Antiemetic Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.3.3. Europe Antiemetic Drugs Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Antiemetic Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Antiemetic Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Antiemetic Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Antiemetic Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.4.3. Asia Pacific Antiemetic Drugs Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Antiemetic Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Antiemetic Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Antiemetic Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Antiemetic Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.5.3. Latin America Antiemetic Drugs Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Antiemetic Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Antiemetic Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Antiemetic Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Antiemetic Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.6.3. MEA Antiemetic Drugs Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Antiemetic Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Antiemetic Drugs Providers
        8.4.1 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
                8.4.1.1 Business Description
                8.4.1.2 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Geographic Operations
                8.4.1.3 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Financial Information
                8.4.1.4 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Product Positions/Portfolio
                8.4.1.5 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Key Developments
        8.4.2 JOHNSON AND JOHNSON
                8.4.2.1 Business Description
                8.4.2.2 JOHNSON AND JOHNSON Geographic Operations
                8.4.2.3 JOHNSON AND JOHNSON Financial Information
                8.4.2.4 JOHNSON AND JOHNSON Product Positions/Portfolio
                8.4.2.5 JOHNSON AND JOHNSON Key Developments
        8.4.3 SANOFI
                8.4.3.1 Business Description
                8.4.3.2 SANOFI Geographic Operations
                8.4.3.3 SANOFI Financial Information
                8.4.3.4 SANOFI Product Positions/Portfolio
                8.4.3.5 SANOFI Key Developments
        8.4.4 MERCK AND CO.
                8.4.4.1 Business Description
                8.4.4.2 MERCK AND CO. Geographic Operations
                8.4.4.3 MERCK AND CO. Financial Information
                8.4.4.4 MERCK AND CO. Product Positions/Portfolio
                8.4.4.5 MERCK AND CO. Key Developments
        8.4.5 NOVARTIS AG
                8.4.5.1 Business Description
                8.4.5.2 NOVARTIS AG Geographic Operations
                8.4.5.3 NOVARTIS AG Financial Information
                8.4.5.4 NOVARTIS AG Product Positions/Portfolio
                8.4.5.5 NOVARTIS AG Key Developments
        8.4.6 BRISTOL-MYERS SQUIBB
                8.4.6.1 Business Description
                8.4.6.2 BRISTOL-MYERS SQUIBB Geographic Operations
                8.4.6.3 BRISTOL-MYERS SQUIBB Financial Information
                8.4.6.4 BRISTOL-MYERS SQUIBB Product Positions/Portfolio
                8.4.6.5 BRISTOL-MYERS SQUIBB Key Developments
        8.4.7 ASTELLAS PHARMA, INC.
                8.4.7.1 Business Description
                8.4.7.2 ASTELLAS PHARMA, INC. Geographic Operations
                8.4.7.3 ASTELLAS PHARMA, INC. Financial Information
                8.4.7.4 ASTELLAS PHARMA, INC. Product Positions/Portfolio
                8.4.7.5 ASTELLAS PHARMA, INC. Key Developments
        8.4.8 ELI LILLY AND COMPANY
                8.4.8.1 Business Description
                8.4.8.2 ELI LILLY AND COMPANY Geographic Operations
                8.4.8.3 ELI LILLY AND COMPANY Financial Information
                8.4.8.4 ELI LILLY AND COMPANY Product Positions/Portfolio
                8.4.8.5 ELI LILLY AND COMPANY Key Developments
        8.4.9 ABBOTT
                8.4.9.1 Business Description
                8.4.9.2 ABBOTT Geographic Operations
                8.4.9.3 ABBOTT Financial Information
                8.4.9.4 ABBOTT Product Positions/Portfolio
                8.4.9.5 ABBOTT Key Developments
        8.4.10 DR. REDDY'S LABORATORIES LTD
                8.4.10.1 Business Description
                8.4.10.2 DR. REDDY'S LABORATORIES LTD Geographic Operations
                8.4.10.3 DR. REDDY'S LABORATORIES LTD Financial Information
                8.4.10.4 DR. REDDY'S LABORATORIES LTD Product Positions/Portfolio
                8.4.10.5 DR. REDDY'S LABORATORIES LTD Key Developments
        8.4.11 Pfizer
                8.4.11.1 Business Description
                8.4.11.2 Pfizer Geographic Operations
                8.4.11.3 Pfizer Financial Information
                8.4.11.4 Pfizer Product Positions/Portfolio
                8.4.11.5 Pfizer Key Developments
        8.4.12 Baxter International
                8.4.12.1 Business Description
                8.4.12.2 Baxter International Geographic Operations
                8.4.12.3 Baxter International Financial Information
                8.4.12.4 Baxter International Product Positions/Portfolio
                8.4.12.5 Baxter International Key Developments
        8.4.13 Cipla Ltd.
                8.4.13.1 Business Description
                8.4.13.2 Cipla Ltd. Geographic Operations
                8.4.13.3 Cipla Ltd. Financial Information
                8.4.13.4 Cipla Ltd. Product Positions/Portfolio
                8.4.13.5 Cipla Ltd. Key Developments
        8.4.14 LGM Pharma
                8.4.14.1 Business Description
                8.4.14.2 LGM Pharma Geographic Operations
                8.4.14.3 LGM Pharma Financial Information
                8.4.14.4 LGM Pharma Product Positions/Portfolio
                8.4.14.5 LGM Pharma Key Developments
        8.4.15 ZETA PHARMA
                8.4.15.1 Business Description
                8.4.15.2 ZETA PHARMA Geographic Operations
                8.4.15.3 ZETA PHARMA Financial Information
                8.4.15.4 ZETA PHARMA Product Positions/Portfolio
                8.4.15.5 ZETA PHARMA Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Antiemetic Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Antiemetic Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Antiemetic Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Antiemetic Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Antiemetic Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Antiemetic Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Antiemetic Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Antiemetic Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Antiemetic Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Antiemetic Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Antiemetic Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Antiemetic Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Antiemetic Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Antiemetic Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Antiemetic Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Antiemetic Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Antiemetic Drugs: Market Segmentation 
FIG. 2 Global Antiemetic Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Antiemetic Drugs Market, By Drug Type, 2019 (US$ Mn) 
FIG. 5 Global Antiemetic Drugs Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Antiemetic Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Antiemetic Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Antiemetic Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Antiemetic Drugs Providers, 2019
FIG. 11 Global Antiemetic Drugs Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 12 Global Antiemetic Drugs Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Antiemetic Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Antiemetic Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Antiemetic Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Antiemetic Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Antiemetic Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Antiemetic Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Antiemetic Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Antiemetic Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Antiemetic Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Antiemetic Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Antiemetic Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Antiemetic Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Antiemetic Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Antiemetic Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Antiemetic Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Antiemetic Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Antiemetic Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Antiemetic Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Antiemetic Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Antiemetic Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Antiemetic Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Antiemetic Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Antiemetic Drugs Market Value, By Country, 2018 – 2028
TABLE  GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  JOHNSON AND JOHNSON: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SANOFI: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MERCK AND CO.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NOVARTIS AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BRISTOL-MYERS SQUIBB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ASTELLAS PHARMA, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ELI LILLY AND COMPANY: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ABBOTT: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DR. REDDY'S LABORATORIES LTD: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Baxter International: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  LGM Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ZETA PHARMA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Antiemetic Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Antiemetic Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Antiemetic Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Antiemetic Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Antiemetic Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Antiemetic Drugs Providers, 2016
FIG.  Global Antiemetic Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Dopamine Antagonists Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NK1 Receptor Antagonist Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antihistamines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cannabinoids Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Benzodiazepines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anticholinergics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antiemetic Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Motion Sickness Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gastroenteritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Opioid Analgesics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Dizziness Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Antiemetic Drugs Market Value, 2018 – 2028, (US$ Mn)